Literature DB >> 9227724

Pulmonary oxidative stress response in young children with cystic fibrosis.

J Hull1, P Vervaart, K Grimwood, P Phelan.   

Abstract

BACKGROUND: It has been suggested that oxidative stress contributes to lung injury in cystic fibrosis. There is, however, no direct evidence of increased pulmonary oxidative stress in cystic fibrosis nor of the effects of inflammation on the major pulmonary antioxidant, glutathione. A study was undertaken to measure these parameters in infants and young children in the presence or absence of pulmonary inflammation.
METHODS: Thirty two infants and young children with cystic fibrosis of mean (SD) age 21.4 (15.3) months (range 2-54) and seven non-cystic fibrosis control subjects of mean (SD) age 21.0 (21.2) months (range 2-54) were studied using bronchoalveolar lavage (BAL). On the basis of the BAL findings the cystic fibrosis group was divided into those with (CF-I) and those without pulmonary inflammation (CF-NI). Levels of lipid hydroperoxide, total glutathione, and gamma-glutamyl transpeptidase (gamma-GT) were then measured in the BAL fluid.
RESULTS: The concentrations of lipid hydroperoxide and gamma-GT in the epithelial lining fluid were significantly increased in the CF-I group compared with the control and CF-NI groups, each of which had similar values for these parameters (ratio of geometric means for CF-I group versus control for lipid hydroperoxide 5.4 (95% confidence interval (CI) 1.8 to 15.8) and for gamma-GT 5.2 (95% CI 1.4 to 19.4)). The glutathione concentration tended to be lower in the CF-I subjects but the difference did not reach statistical significance.
CONCLUSIONS: These results demonstrate that the airways in patients with cystic fibrosis are exposed to increased oxidative stress which appears to be a consequence of pulmonary inflammation rather than part of the primary cystic fibrosis defect. The increase in gamma-GT in the CF-I group suggests a mechanism by which extracellular glutathione could be utilised by airway epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227724      PMCID: PMC1758593          DOI: 10.1136/thx.52.6.557

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  11 in total

1.  Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.

Authors:  D S Armstrong; K Grimwood; J B Carlin; R Carzino; A Olinsky; P D Phelan
Journal:  Pediatr Pulmonol       Date:  1996-05

2.  Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress.

Authors:  R K Brown; H Wyatt; J F Price; F J Kelly
Journal:  Eur Respir J       Date:  1996-02       Impact factor: 16.671

3.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

Authors:  S I Rennard; G Basset; D Lecossier; K M O'Donnell; P Pinkston; P G Martin; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1986-02

4.  Normal alveolar epithelial lining fluid contains high levels of glutathione.

Authors:  A M Cantin; S L North; R C Hubbard; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1987-07

5.  Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis.

Authors:  B C Portal; M J Richard; H S Faure; A J Hadjian; A E Favier
Journal:  Am J Clin Nutr       Date:  1995-04       Impact factor: 7.045

6.  Systemic deficiency of glutathione in cystic fibrosis.

Authors:  J H Roum; R Buhl; N G McElvaney; Z Borok; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1993-12

7.  gamma-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells.

Authors:  A Kugelman; H A Choy; R Liu; M M Shi; E Gozal; H J Forman
Journal:  Am J Respir Cell Mol Biol       Date:  1994-11       Impact factor: 6.914

8.  Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals.

Authors:  A Meyer; R Buhl; S Kampf; H Magnussen
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

9.  Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria.

Authors:  J F Turrens; A Boveris
Journal:  Biochem J       Date:  1980-11-01       Impact factor: 3.857

10.  Calcium metabolism and cystic fibrosis: mitochondrial abnormalities suggest a modification of the mitochondrial membrane.

Authors:  A A von Ruecker; R Bertele; H K Harms
Journal:  Pediatr Res       Date:  1984-07       Impact factor: 3.756

View more
  37 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Anti-Pseudomonas aeruginosa IgY Antibodies Induce Specific Bacterial Aggregation and Internalization in Human Polymorphonuclear Neutrophils.

Authors:  K Thomsen; L Christophersen; T Bjarnsholt; P Ø Jensen; C Moser; N Høiby
Journal:  Infect Immun       Date:  2015-04-20       Impact factor: 3.441

Review 3.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

4.  Increased carbon monoxide in exhaled air of patients with cystic fibrosis.

Authors:  P Paredi; P L Shah; P Montuschi; P Sullivan; M E Hodson; S A Kharitonov; P J Barnes
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

Review 5.  Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Authors:  Anders Folkesson; Lars Jelsbak; Lei Yang; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Søren Molin
Journal:  Nat Rev Microbiol       Date:  2012-11-13       Impact factor: 60.633

6.  Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis.

Authors:  J Hull; A H Thomson
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

Review 7.  Antibiotic and anti-inflammatory therapies for cystic fibrosis.

Authors:  James F Chmiel; Michael W Konstan; J Stuart Elborn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

8.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

9.  High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis.

Authors:  Rabindra Tirouvanziam; Carol K Conrad; Teodoro Bottiglieri; Leonore A Herzenberg; Richard B Moss; Leonard A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

Review 10.  Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling.

Authors:  David Nichols; James Chmiel; Melvin Berger
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.